Kovitz Investment Group Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$288M Buy
710,807
+79,465
+13% +$32.2M 1.23% 13
2025
Q1
$314M Buy
631,342
+154,727
+32% +$77M 1.58% 7
2024
Q4
$248M Buy
476,615
+431,576
+958% +$225M 1.22% 15
2024
Q3
$23.8M Buy
45,039
+8,875
+25% +$4.7M 0.17% 112
2024
Q2
$20M Buy
36,164
+6,246
+21% +$3.45M 0.17% 98
2024
Q1
$17.4M Buy
29,918
+20,265
+210% +$11.8M 0.22% 66
2023
Q4
$5.12M Sell
9,653
-1,513
-14% -$803K 0.08% 147
2023
Q3
$5.65M Buy
11,166
+202
+2% +$102K 0.1% 118
2023
Q2
$5.72M Buy
10,964
+1,399
+15% +$730K 0.08% 126
2023
Q1
$5.51M Sell
9,565
-1,048
-10% -$604K 0.1% 136
2022
Q4
$5.84M Buy
10,613
+165
+2% +$90.9K 0.12% 130
2022
Q3
$5.3M Sell
10,448
-298
-3% -$151K 0.12% 134
2022
Q2
$5.84M Buy
10,746
+134
+1% +$72.8K 0.13% 122
2022
Q1
$6.27M Buy
10,612
+9,885
+1,360% +$5.84M 0.12% 132
2021
Q4
$338K Sell
727
-10,852
-94% -$5.05M 0.01% 354
2021
Q3
$6.62M Sell
11,579
-1,214
-9% -$694K 0.13% 114
2021
Q2
$6.45M Buy
12,793
+9,568
+297% +$4.83M 0.13% 121
2021
Q1
$1.47M Buy
3,225
+2,499
+344% +$1.14M 0.03% 237
2020
Q4
$338K Buy
726
+82
+13% +$38.2K 0.01% 351
2020
Q3
$284K Buy
644
+10
+2% +$4.41K 0.01% 355
2020
Q2
$230K Buy
+634
New +$230K 0.01% 349
2020
Q1
Sell
-802
Closed -$261K 386
2019
Q4
$261K Buy
802
+31
+4% +$10.1K 0.01% 348
2019
Q3
$225K Buy
771
+12
+2% +$3.5K 0.01% 346
2019
Q2
$223K Buy
+759
New +$223K 0.01% 337
2019
Q1
Sell
-1,138
Closed -$255K 366
2018
Q4
$255K Sell
1,138
-300
-21% -$67.2K 0.01% 240
2018
Q3
$351K Buy
1,438
+350
+32% +$85.4K 0.02% 125
2018
Q2
$225K Buy
+1,088
New +$225K 0.01% 137